KPC Pharmaceuticals, Inc.

KPC Pharmaceuticals, Inc.verified

600422.SS

Price:

$12.46

Market Cap:

$9.43B

KPC Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemether, panax notoginseng, and gastrodine series drugs, as well as Chinese medicines and ethnic drugs under the Luotai, Tianxuanqing, Artemedine, Artem, and Arco brand names for treating cardio-cerebral-vascular and nervous system diseases, as well as malaria. The company also provides Dai medicines; antibiotics, chemical medicinal raw materials, chemical pharmaceutical preparations, traditional Chinese medicinal materials, biological products, biochemical drugs, an...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2000-12-06

Stock Exchange

SHH

Ticker

600422.SS

The PE Ratio as of December 2025 (TTM) for KPC Pharmaceuticals, Inc. (600422.SS) is 19.78

According to KPC Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 19.78. This represents a change of -27.77% compared to the average of 27.38 of the last 4 quarters.

KPC Pharmaceuticals, Inc. (600422.SS) Historical PE Ratio (quarterly & annually)

How has 600422.SS PE Ratio performed in the past?

The mean historical PE Ratio of KPC Pharmaceuticals, Inc. over the last ten years is 22.34. The current 19.78 PE Ratio has changed 8.75% with respect to the historical average. Over the past ten years (40 quarters), 600422.SS's PE Ratio was at its highest in in the December 2022 quarter at 190.81. The PE Ratio was at its lowest in in the March 2021 quarter at 8.09.

Quarterly (TTM)
Annual

Average

22.34

Median

20.16

Minimum

13.81

Maximum

37.31

KPC Pharmaceuticals, Inc. (600422.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of KPC Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 67.75%

Maximum Annual PE Ratio = 37.31

Minimum Annual Increase = -36.98%

Minimum Annual PE Ratio = 13.81

Quarterly (TTM)
Annual
YearPE RatioChange
202418.43-36.98%
202329.255.63%
202227.6967.75%
202116.5014.82%
202014.37-20.07%
201917.9830.20%
201813.81-36.93%
201721.90-16.35%
201626.18-29.83%
201537.3110.19%

KPC Pharmaceuticals, Inc. (600422.SS) Average PE Ratio

How has 600422.SS PE Ratio performed in the past?

The current PE Ratio of KPC Pharmaceuticals, Inc. (600422.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

25.12

5-year avg

21.25

10-year avg

22.34

KPC Pharmaceuticals, Inc. (600422.SS) PE Ratio vs. Peers

How is 600422.SS’s PE Ratio compared to its peers?

KPC Pharmaceuticals, Inc.’s PE Ratio is greater than Cisen Pharmaceutical Co., Ltd. (16.62), less than Tianjin Ringpu Bio-Technology Co.,Ltd. (21.27), less than Harbin Pharmaceutical Group Co., Ltd. (20.13), less than Shandong Xinhua Pharmaceutical Company Limited (28.63), less than North China Pharmaceutical Company Ltd. (52.96), greater than Zhejiang Hisoar Pharmaceutical Co., Ltd. (-28.35), less than Zhejiang Xianju Pharmaceutical Co.,Ltd. (33.22), greater than Renhe Pharmacy Co., Ltd. (18.25), less than Changzhou Qianhong Biopharma CO.,LTD (22.98), less than Northeast Pharmaceutical Group Co., Ltd. (20.46),

Build a custom stock screener for KPC Pharmaceuticals, Inc. (600422.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like KPC Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

KPC Pharmaceuticals, Inc. (600422.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like KPC Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is KPC Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for KPC Pharmaceuticals, Inc. (600422.SS)?

What is the highest PE Ratio for KPC Pharmaceuticals, Inc. (600422.SS)?

What is the 3-year average PE Ratio for KPC Pharmaceuticals, Inc. (600422.SS)?

What is the 5-year average PE Ratio for KPC Pharmaceuticals, Inc. (600422.SS)?

How does the current PE Ratio for KPC Pharmaceuticals, Inc. (600422.SS) compare to its historical average?